Hannah Messinger

Senior Medical Communications Officer, Penn Medicine

New approach for brain cell immunotherapy

Penn Medicine researchers have developed a selective medicine to get rid of old microglia, while also replenishing them with transplanted surrogate cells in their place, suggesting future potential for treating and even preventing neurodegenerative disorders.

Hannah Messinger